Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fragment‐based drug discovery—the importance of high‐quality molecule libraries
Marta Bon, Alan Bilsland, Justin Bower, et al.
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3761-3777
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade
Liuying Wang, Yongzhen Song, Hesong Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 253-253
Open Access | Times Cited: 48
Mpox (formerly monkeypox): pathogenesis, prevention and treatment
Junjie Lu, Hui Xing, Chunhua Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 46
Applications and prospects of cryo-EM in drug discovery
Kongfu Zhu, Chuang Yuan, Yongming Du, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Discovery and Validation of the Binding Poses of Allosteric Fragment Hits to Protein Tyrosine Phosphatase 1b: From Molecular Dynamics Simulations to X-ray Crystallography
Jack B. Greisman, Lindsay Willmore, Christine Y. Yeh, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 9, pp. 2644-2650
Open Access | Times Cited: 20
Fragment-to-Lead Medicinal Chemistry Publications in 2022
Andrew J. Woodhead, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2287-2304
Closed Access | Times Cited: 11
Multi-tiered chemical proteomic maps of tryptoline acrylamide–protein interactions in cancer cells
Evert Njomen, Rachel E. Hayward, Kristen E. DeMeester, et al.
Nature Chemistry (2024) Vol. 16, Iss. 10, pp. 1592-1604
Closed Access | Times Cited: 9
Fragment-to-Lead Medicinal Chemistry Publications in 2023
Rhian S. Holvey, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2025) Vol. 68, Iss. 2, pp. 986-1001
Closed Access
Different applications and differentiated libraries for crystallographic fragment screening
Jessica E. Watt, Mathew P. Martin, Jane Endicott, et al.
Current Opinion in Structural Biology (2025) Vol. 90, pp. 102982-102982
Open Access
Fragment-Based Drug Discovery of KIF11 Inhibitors for Glioblastoma Treatment: Molecular Insights and Therapeutic Potential
Qais Ahmad Naseer, Cao Xuexian, Deng Yimai, et al.
Drug Research (2025)
Closed Access
Fragment-based drug discovery: Small fragments, big impact − Success stories of approved oncology therapeutics
Nilesh Raghunath Khedkar, Milind Sindkhedkar, Alex Joseph
Bioorganic Chemistry (2025) Vol. 156, pp. 108197-108197
Closed Access
Evaluation of the Recent Dynamics for Funding Medicinal Chemistry Projects in Academia. Results of a Survey Conducted by IUPAC Division VII (Chemistry and Human Health)
Ayelet Rothstein, Mukund S. Chorghade, Hassan Ibrahim, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Stabilized cyclic peptides as modulators of protein–protein interactions: promising strategies and biological evaluation
Jiongjia Cheng, Junlong Zhou, Lingyan Kong, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2496-2508
Closed Access | Times Cited: 15
Time-series analysis of rhenium(I) organometallic covalent binding to a model protein for drug development
Frederick J. F. Jacobs, John R. Helliwell, Alice Brink
IUCrJ (2024) Vol. 11, Iss. 3, pp. 359-373
Open Access | Times Cited: 5
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
Kirsten McAulay, Alan Bilsland, Marta Bon
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 21
Repurposing sodium stibogluconate as an uracil DNA glycosylase inhibitor against prostate cancer using a time-resolved oligonucleotide-based drug screening platform
Sang-Cuo Nao, Le-Sheng Huang, Daniel Shiu‐Hin Chan, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107176-107176
Closed Access | Times Cited: 3
Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collection
Xavier Jalencas, Hannes Berg, Ludvik Olai Espeland, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 4, pp. 1176-1188
Open Access | Times Cited: 3
Linkers in fragment-based drug design: an overview of the literature
D. Grenier, Solène Audebert, Jordane Preto, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 9, pp. 987-1009
Closed Access | Times Cited: 10
Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets
Guixian Zhao, Mengping Zhu, Yangfeng Li, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 6, pp. 725-740
Closed Access | Times Cited: 3
Fragment-based drug discovery campaigns guided by native mass spectrometry
Louise M. Sternicki, Sally‐Ann Poulsen
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2270-2285
Closed Access | Times Cited: 3
Does artificial intelligence need companionship to assist in drug discovery? The Kirsten rat sarcoma virus study
Mourad Stitou, John M. Koomen, Denis Imbody, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 2
The Role of 3D Bioprinting in Drug Discovery: A review
Abrar Hussain, Tamanna Rajpoot, Marium Rehman
Journal of advanced Biomedical and Pharmaceutical Sciences (2024), pp. 88-95
Open Access | Times Cited: 2
High Throughput Screening in Drug Discovery: Problems and Solutions
Dmitry M. Hushpulian, Irina N. Gaisina, С. В. Никулин, et al.
Moscow University Chemistry Bulletin (2024) Vol. 79, Iss. 2, pp. 93-104
Closed Access | Times Cited: 2
Advanced technologies for screening and identifying covalent inhibitors
Yaolin Guo, Shuai Wen, Aiping Tong, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117833-117833
Closed Access | Times Cited: 2
Synthesis of Ethyl Pyrimidine-Quinolincarboxylates Selected from Virtual Screening as Enhanced Lactate Dehydrogenase (LDH) Inhibitors
Iván Díaz, Sofı́a Salido, Manuel Nogueras, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9744-9744
Open Access | Times Cited: 2
Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets
Kilian Colas, Daniel Bindl, Hiroaki Suga
Chemical Reviews (2024) Vol. 124, Iss. 21, pp. 12213-12241
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top